Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
$0.38
-11.9%
$0.34
$0.23
$1.35
$16.57M0.9314.65 million shs1.67 million shs
PolyPid Ltd. stock logo
PYPD
PolyPid
$3.15
-5.4%
$3.41
$2.30
$3.93
$52.86M1.551,256 shs380,892 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$3.28
-3.5%
$3.43
$3.03
$9.33
$55.90M1.3889,510 shs60,065 shs
SurgePays, Inc. stock logo
SURG
SurgePays
$2.65
-1.1%
$2.73
$1.05
$3.47
$54.76M0.4394,342 shs55,214 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
-11.86%-1.28%+23.61%+51.60%-72.13%
PolyPid Ltd. stock logo
PYPD
PolyPid
-5.41%-10.00%-8.70%-6.80%-12.74%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
-3.53%-4.37%+2.50%-21.15%-48.10%
SurgePays, Inc. stock logo
SURG
SurgePays
-1.12%-2.21%-6.36%-15.61%+57.74%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
$0.38
-11.9%
$0.34
$0.23
$1.35
$16.57M0.9314.65 million shs1.67 million shs
PolyPid Ltd. stock logo
PYPD
PolyPid
$3.15
-5.4%
$3.41
$2.30
$3.93
$52.86M1.551,256 shs380,892 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$3.28
-3.5%
$3.43
$3.03
$9.33
$55.90M1.3889,510 shs60,065 shs
SurgePays, Inc. stock logo
SURG
SurgePays
$2.65
-1.1%
$2.73
$1.05
$3.47
$54.76M0.4394,342 shs55,214 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
-11.86%-1.28%+23.61%+51.60%-72.13%
PolyPid Ltd. stock logo
PYPD
PolyPid
-5.41%-10.00%-8.70%-6.80%-12.74%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
-3.53%-4.37%+2.50%-21.15%-48.10%
SurgePays, Inc. stock logo
SURG
SurgePays
-1.12%-2.21%-6.36%-15.61%+57.74%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
2.50
Moderate Buy$5.501,351.19% Upside
PolyPid Ltd. stock logo
PYPD
PolyPid
2.86
Moderate Buy$12.40293.65% Upside
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
2.20
Hold$8.00143.90% Upside
SurgePays, Inc. stock logo
SURG
SurgePays
2.00
Hold$9.50258.49% Upside

Current Analyst Ratings Breakdown

Latest CODX, SRTS, PYPD, and SURG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/8/2025
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
10/8/2025
PolyPid Ltd. stock logo
PYPD
PolyPid
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
10/8/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D)
10/8/2025
SurgePays, Inc. stock logo
SURG
SurgePays
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
10/3/2025
SurgePays, Inc. stock logo
SURG
SurgePays
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$9.00 ➝ $9.50
9/27/2025
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
9/27/2025
PolyPid Ltd. stock logo
PYPD
PolyPid
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
9/27/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D)
9/27/2025
SurgePays, Inc. stock logo
SURG
SurgePays
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
9/23/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHoldStrong Sell
9/17/2025
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
D. Boral Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$10.00
(Data available from 10/11/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
$3.91M3.73N/AN/A$1.70 per share0.22
PolyPid Ltd. stock logo
PYPD
PolyPid
N/AN/AN/AN/A$0.75 per shareN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$41.81M1.29$0.42 per share7.87$3.41 per share0.96
SurgePays, Inc. stock logo
SURG
SurgePays
$60.88M0.89N/AN/A$0.76 per share3.49
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
-$37.64M-$1.15N/AN/AN/A-3,588.33%-69.49%-60.49%11/6/2025 (Estimated)
PolyPid Ltd. stock logo
PYPD
PolyPid
-$29.02M-$3.83N/AN/AN/A-453.95%-138.92%11/12/2025 (Estimated)
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$6.65M-$0.06N/A14.26N/A-2.26%-1.58%-1.41%11/13/2025 (Estimated)
SurgePays, Inc. stock logo
SURG
SurgePays
-$45.73M-$2.49N/AN/AN/A-133.85%-333.87%-195.36%11/11/2025 (Estimated)

Latest CODX, SRTS, PYPD, and SURG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/6/2025Q3 2025
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
-$0.19N/AN/AN/AN/AN/A
8/14/2025Q2 2025
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
-$0.25-$0.23+$0.02-$0.23$0.30 million$0.16 million
8/13/2025Q2 2025
PolyPid Ltd. stock logo
PYPD
PolyPid
-$0.53-$0.78-$0.25-$0.78N/AN/A
8/13/2025Q2 2025
SurgePays, Inc. stock logo
SURG
SurgePays
-$0.31-$0.36-$0.05-$0.36$16.14 million$11.52 million
8/7/2025Q2 2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.01-$0.06-$0.07-$0.06$9.30 million$7.32 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
N/AN/AN/AN/AN/A
PolyPid Ltd. stock logo
PYPD
PolyPid
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
SurgePays, Inc. stock logo
SURG
SurgePays
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
N/A
4.12
3.83
PolyPid Ltd. stock logo
PYPD
PolyPid
N/A
2.28
2.28
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
8.14
5.79
SurgePays, Inc. stock logo
SURG
SurgePays
101.87
1.11
0.84

Institutional Ownership

CompanyInstitutional Ownership
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
14.99%
PolyPid Ltd. stock logo
PYPD
PolyPid
26.47%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%
SurgePays, Inc. stock logo
SURG
SurgePays
6.94%

Insider Ownership

CompanyInsider Ownership
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
8.40%
PolyPid Ltd. stock logo
PYPD
PolyPid
24.70%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
8.90%
SurgePays, Inc. stock logo
SURG
SurgePays
30.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
10038.52 million35.29 millionOptionable
PolyPid Ltd. stock logo
PYPD
PolyPid
8015.90 million11.97 millionNo Data
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
4016.44 million14.98 millionOptionable
SurgePays, Inc. stock logo
SURG
SurgePays
4020.43 million14.20 millionOptionable

Recent News About These Companies

Surgepays Unveils Growth Strategy Amid Stock Volatility
SurgePays CFO Anthony Evers to Depart by Year-End
Thomas Hughes | Page 3
8 Most Undervalued Telecom Stocks to Invest In
Phone-in-a-Box Prepaid Service Smartphones
SurgePays, Inc. (SURG) Q2 2025 Earnings Call Transcript

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Co-Diagnostics stock logo

Co-Diagnostics NASDAQ:CODX

$0.38 -0.05 (-11.86%)
Closing price 10/10/2025 04:00 PM Eastern
Extended Trading
$0.38 0.00 (-1.06%)
As of 10/10/2025 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

PolyPid stock logo

PolyPid NASDAQ:PYPD

$3.15 -0.18 (-5.41%)
Closing price 10/10/2025 04:00 PM Eastern
Extended Trading
$3.18 +0.03 (+0.95%)
As of 10/10/2025 07:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PolyPid Ltd., a clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. It is also developing OncoPLEX, for the treatment of intra-tumoral cancer. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$3.28 -0.12 (-3.53%)
Closing price 10/10/2025 04:00 PM Eastern
Extended Trading
$3.24 -0.04 (-1.19%)
As of 10/10/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

SurgePays stock logo

SurgePays NASDAQ:SURG

$2.65 -0.03 (-1.12%)
Closing price 10/10/2025 04:00 PM Eastern
Extended Trading
$2.68 +0.03 (+1.13%)
As of 10/10/2025 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SurgePays, Inc., together with its subsidiaries, operates as a financial technology and telecom company in the United States. It operates through three segments: Mobile Virtual Network Operators, Comprehensive Platform Services, and Lead Generation. The company offers subsidized and non-subsidized mobile virtual network operators for internet connectivity through mobile broadband services to consumers; ACH banking relationships and fintech transactions platform to convenience stores; wireless top-up transactions and wireless product aggregation; and lead generation and case management solutions primarily to law firms in the mass tort industry, as well as call center activities. SurgePays, Inc. is headquartered in Bartlett, Tennessee.